Collaborative action between tumor cells and host-derived suppressor cells leads to peripheral tolerance of T cells to tumor antigens. Here, we showed that in tumor-bearing mice, generation of tumor antigen-specific effector T-helper cells (T H 1) was significantly attenuated, and impaired T H 1 differentiation was restored by the temporal blockade of interleukin (IL)-6 activity at the T-cell priming phase. Furthermore, we found that Gr-1 þ myeloid-derived suppressor cells (MDSC) served as a source of IL-6 in tumor-bearing mice. Adoptive transfer of effector CD4 þ T cells revealed that MDSC-sensitized effector CD4 þ T cells were less potent in mounting antitumor immune responses, although effector T cells generated together with Gr-1 þ cells from tumor-free mice eradicated established tumors. CD8 þ T cells, IFN-g, and MHC-class II expression in host mice were indispensable for the antitumor activity initiated by effector CD4 þ T cells. Despite comparable suppressive activity of IL-6 þ/þ and IL-6 À/À MDSC on primary T-cell activation, transfer of IL-6 þ/þ MDSC, but not IL-6 À/À MDSC, dampened the efficient induction of effector T H 1 cells and counteracted CD4 þ T cell-mediated antitumor immunity including cognate help for CD8 þ T cells in vivo. These findings suggest that, apart from the inhibitory effects on primary T-cell activation, MDSC promote tumor progression by attenuating functional differentiation of tumor-specific CD4 þ T cells into effector T H 1 cells through IL-6 production to promote tumor progression. This novel mode of MDSC-induced tolerance of effector CD4 þ T cells should be considered as the basis for the rational design of effective T cell-mediated antitumor therapies.